Table 3.
Clinical outcomes at 3 years according to stages in VAMT group patients.
| FIGO Stage | Number of patients | Crude LC rate | Crude PC rate | Crude RC rate | Crude DMFS | OS at 3 year | DFS at 3 year | LC at 3 year | DMFS at 3 year |
|---|---|---|---|---|---|---|---|---|---|
| IA | 1 | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% |
| IB | 14 | 100% | 100% | 100% | 92.9% | 100% | 92.3% | 100% | 92.3% |
| IIA | 41 | 90.2% | 82.9% | 80.5% | 82.9% | 85.7% | 73.5% | 92.0% | 83.5% |
| IIB | 138 | 87.7% | 86.2% | 84.1% | 87.7% | 79.2% | 67.9% | 86.8% | 85.8% |
| IIIA | 29 | 96.6% | 93.1% | 93.1% | 75.9% | 75.6% | 72.4% | 96.2% | 75.3% |
| IIIB | 91 | 89% | 85.7% | 83.5% | 75.8% | 82% | 59.9% | 87.7% | 71.8% |
| IVA | 2 | 100% | 100% | 100% | 50% | – | – | – | – |
| IVB | 15 | 80% | 80% | 80% | 53.3 | 60.1% | 34.5% | 78.3% | 49.0% |
| overall | 331 | 89.4% | 86.7% | 84.9% | 81.3 | – | – | – | – |